Crossref
Role of biomarkers and electrocardiography assessment as individual predictors of anthracycline cardiotoxicity in lymphoma patients
OncoReview · 2019
DOI: 10.24292/01.or.271218 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoReview, 2019. Verfasst von Monika Długosz-Danecka und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Długosz-Danecka, M., Jaroszyński, A., & Jurczak, W. (2019). Role of biomarkers and electrocardiography assessment as individual predictors of anthracycline cardiotoxicity in lymphoma patients. OncoReview. https://doi.org/10.24292/01.or.271218
Vancouver
Długosz-Danecka M, Jaroszyński A, Jurczak W. Role of biomarkers and electrocardiography assessment as individual predictors of anthracycline cardiotoxicity in lymphoma patients. OncoReview. 2019. doi:10.24292/01.or.271218
BibTeX
@article{DugoszDanecka2019,
author = {Długosz-Danecka, Monika and Jaroszyński, Andrzej and Jurczak, Wojciech},
title = {Role of biomarkers and electrocardiography assessment as individual predictors of anthracycline cardiotoxicity in lymphoma patients},
journal = {OncoReview},
year = {2019},
doi = {10.24292/01.or.271218}
}
EUVIMED